{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:02Z","timestamp":1791828542240,"version":"4.3.4"},"reference-count":54,"publisher":"The Endocrine Society","issue":"Supplement_1","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a rare genetic condition that requires lifelong management from birth. Individuals with CAH and their families often face structural barriers to obtaining comprehensive care and treatment, including limited access to appropriate newborn screening, comprehensive care centers, and medications. Social and cultural barriers to care may include stigmatization, discrimination, and adverse medical experiences. At the individual and family level, comprehensive care may be affected by education, finances, health-care coverage, geographic location, and lack of social supports. These barriers are often further magnified for individuals living in underresourced countries. Inadequate access to comprehensive care and medications increases the risk of life-threatening adrenal crisis and disease-related comorbidities. This review article examines the current structural, sociocultural, and individual barriers that individuals with CAH and their families may face when managing their condition throughout their lifetime.<\/jats:p>","DOI":"10.1210\/clinem\/dgae710","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T17:04:16Z","timestamp":1737479056000},"page":"S67-S73","source":"Crossref","is-referenced-by-count":5,"title":["Barriers to the Management of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5310-1057","authenticated-orcid":false,"given":"Kelsey B","family":"Eitel","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Washington School of Medicine, Seattle Children's Hospital , Seattle, WA 98105 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1243-8304","authenticated-orcid":false,"given":"Patricia Y","family":"Fechner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Washington School of Medicine, Seattle Children's Hospital , Seattle, WA 98105 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"issue":"13","key":"2025012117040311900_dgae710-B1","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N Engl J Med"},{"issue":"10372","key":"2025012117040311900_dgae710-B2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(22)01330-7","article-title":"Congenital adrenal hyperplasia","volume":"401","author":"Auer","year":"2023","journal-title":"Lancet"},{"issue":"11","key":"2025012117040311900_dgae710-B3","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025012117040311900_dgae710-B4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/endrev\/bnab016","article-title":"Congenital adrenal hyperplasia: current insights in pathophysiology, diagnostics, and management","volume":"43","author":"Claahsen-van der Grinten","year":"2022","journal-title":"Endocr Rev"},{"issue":"6","key":"2025012117040311900_dgae710-B5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41574-022-00655-w","article-title":"Management challenges and therapeutic advances in congenital adrenal hyperplasia","volume":"18","author":"Mallappa","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"10108","key":"2025012117040311900_dgae710-B6","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet"},{"key":"2025012117040311900_dgae710-B7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/cen.14967","article-title":"Long-term health consequences of congenital adrenal hyperplasia","volume":"101","author":"Pofi","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025012117040311900_dgae710-B8","author":"CARES Foundation"},{"issue":"5","key":"2025012117040311900_dgae710-B9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-45-5-1003","article-title":"Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia","volume":"45","author":"Pang","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025012117040311900_dgae710-B10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/ijns10020038","article-title":"Current status of newborn bloodspot screening worldwide 2024: a comprehensive review of recent activities (2020\u20132023)","volume":"10","author":"Therrell","year":"2024","journal-title":"Int J Neonatal Screen"},{"issue":"1","key":"2025012117040311900_dgae710-B11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12887-015-0529-y","article-title":"Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study","volume":"15","author":"Tsuji","year":"2015","journal-title":"BMC Pediatr"},{"key":"2025012117040311900_dgae710-B12","author":"Australian Government Department of Health and Aged Care"},{"issue":"9","key":"2025012117040311900_dgae710-B13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4066\/AMJ.2015.2482","article-title":"Newborn bloodspot screening policy framework for Australia","volume":"8","author":"O'Leary","year":"2015","journal-title":"Australas Med J"},{"issue":"1","key":"2025012117040311900_dgae710-B14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ijns8010008","article-title":"Successful implementation of expanded newborn screening in the Philippines using tandem mass spectrometry","volume":"8","author":"Padilla","year":"2022","journal-title":"Int J Neonatal Screen"},{"key":"2025012117040311900_dgae710-B15","doi-asserted-by":"crossref","first-page":"2326409816661356","DOI":"10.1177\/2326409816661356","article-title":"SUMA technology and newborn screening tests for inherited metabolic diseases in Cuba:an overview of the first 30 years","volume":"4","author":"Gonz\u00e1lez Reyes","year":"2016","journal-title":"J Inborn Errors Metab Screen"},{"key":"2025012117040311900_dgae710-B16","doi-asserted-by":"crossref","first-page":"648939","DOI":"10.3389\/fped.2021.648939","article-title":"Current status of newborn screening in Southeastern Europe","volume":"9","author":"Koracin","year":"2021","journal-title":"Front Pediatr"},{"issue":"11","key":"2025012117040311900_dgae710-B17","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/sj.gt.3301018","article-title":"Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochromeP450 21-hydroxylase into the adrenal gland of21-hydroxylase-deficient mice","volume":"6","author":"Tajima","year":"1999","journal-title":"Gene Ther"},{"issue":"3","key":"2025012117040311900_dgae710-B18","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1210\/jc.2014-3168","article-title":"Newborn screening for congenital adrenal hyperplasia in New Zealand, 1994-2013","volume":"100","author":"Heather","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025012117040311900_dgae710-B19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/ijns8040056","article-title":"Evaluation of a new laboratory protocol for newborn screening for congenital adrenal hyperplasia in New Zealand","volume":"8","author":"de Hora","year":"2022","journal-title":"Int J Neonatal Screen"},{"issue":"Suppl 1","key":"2025012117040311900_dgae710-B20","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.11622\/smedj.2021073","article-title":"Evolution and expansion of newborn screening programmes in Singapore","volume":"62","author":"Rajadurai","year":"2021","journal-title":"Singapore Med J"},{"issue":"3","key":"2025012117040311900_dgae710-B21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/ijns6030063","article-title":"Evaluation of a two-tier screening pathway for congenital adrenal hyperplasia in the New South Wales newborn screening programme","volume":"6","author":"Lai","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"2025012117040311900_dgae710-B22"},{"issue":"6","key":"2025012117040311900_dgae710-B23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamapediatrics.2013.5321","article-title":"Nationwide neonatal screening for congenital adrenal hyperplasia in Sweden: a 26-year longitudinal prospective population-based study","volume":"168","author":"Gidl\u00f6f","year":"2014","journal-title":"JAMA Pediatr"},{"key":"2025012117040311900_dgae710-B24"},{"issue":"3","key":"2025012117040311900_dgae710-B25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/ijns6030070","article-title":"CAH newborn screening in India: challenges and opportunities","volume":"6","author":"Dabas","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"2","key":"2025012117040311900_dgae710-B26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/ijcfm.ijcfm_6_23","article-title":"Evolution of newborn screening in India and the way forward","volume":"9","author":"Darshan","year":"2023","journal-title":"Indian J Community Family Med"},{"issue":"2","key":"2025012117040311900_dgae710-B27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ecl.2017.01.008","article-title":"Genetics of congenital adrenal hyperplasia","volume":"46","author":"Hannah-Shmouni","year":"2017","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2025012117040311900_dgae710-B28","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/jgc4.1804","article-title":"Landscape of genetic counseling in the Philippines","volume":"33","author":"Abad","year":"2024","journal-title":"J Genet Couns"},{"issue":"1","key":"2025012117040311900_dgae710-B29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13023-021-01804-6","article-title":"Genetic counseling in the context of Bangladesh: current scenario, challenges, and a framework for genetic service implementation","volume":"16","author":"Hosen","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"2025012117040311900_dgae710-B30","doi-asserted-by":"crossref","first-page":"275213","DOI":"10.1186\/1687-9856-2010-275213","article-title":"Guidelines for the development of comprehensive care centers for congenital adrenal hyperplasia: guidance from the CARES foundation initiative","volume":"2010","author":"Auchus","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"key":"2025012117040311900_dgae710-B31","author":"CARES Foundation"},{"key":"2025012117040311900_dgae710-B32","author":"National Organization for Rare Disorders (NORD)"},{"key":"2025012117040311900_dgae710-B33","author":"Association of American Medical Colleges (AAMC)"},{"issue":"3","key":"2025012117040311900_dgae710-B34","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0022-3476(69)80280-5","article-title":"An unusually high incidence of salt-losing congenital adrenal hyperplasia in the Alaskan Eskimo","volume":"75","author":"Hirschfeld","year":"1969","journal-title":"J Pediatr"},{"issue":"3","key":"2025012117040311900_dgae710-B35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1210\/jcem-55-3-413","article-title":"A pilot newborn screening for congenital adrenal hyperplasia in Alaska","volume":"55","author":"Pang","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"2025012117040311900_dgae710-B36","volume-title":"Alaska's Physician Workforce in 2021","author":"Dahal","year":"2022"},{"issue":"1","key":"2025012117040311900_dgae710-B37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/jim-2019-000999","article-title":"Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings","volume":"68","author":"Miller","year":"2020","journal-title":"J Investig Med"},{"issue":"1","key":"2025012117040311900_dgae710-B38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/cen.12053","article-title":"The challenge of delivering endocrine care and successful transition to adult services in adolescents with congenital adrenal hyperplasia: experience in a single centre over 18 years","volume":"78","author":"Gleeson","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2025012117040311900_dgae710-B39","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","author":"Arlt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2025012117040311900_dgae710-B40","doi-asserted-by":"crossref","first-page":"1122435","DOI":"10.3389\/fendo.2023.1122435","article-title":"The clinical characteristics and quality of life of 248 pediatric and adult patients with congenital adrenal hyperplasia","volume":"14","author":"Shafaay","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2025012117040311900_dgae710-B41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/0974150X221149837","article-title":"How the birth of a girl child with congenital adrenal hyperplasia changed the mother's life: a case study","volume":"19","author":"Verma","year":"2023","journal-title":"Nurs Midwifery Res J"},{"key":"2025012117040311900_dgae710-B42"},{"issue":"4","key":"2025012117040311900_dgae710-B43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/0974-7796.120308","article-title":"Long-term outcome of genital reconstruction of middle eastern women with congenital adrenal hyperplasia","volume":"5","author":"Seyam","year":"2013","journal-title":"Urol Ann"},{"issue":"4","key":"2025012117040311900_dgae710-B44","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10508-017-1003-8","article-title":"Stigma associated with classical congenital adrenal hyperplasia in women's sexual lives","volume":"47","author":"Meyer-Bahlburg","year":"2018","journal-title":"Arch Sex Behav"},{"issue":"5","key":"2025012117040311900_dgae710-B45","first-page":"496","article-title":"Stigma in medical settings as reported retrospectively by women with congenital adrenal hyperplasia (CAH) for their childhood and adolescence","volume":"42","author":"Meyer-Bahlburg","year":"2017","journal-title":"J Pediatr Psychol"},{"issue":"1","key":"2025012117040311900_dgae710-B46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/cen.13054","article-title":"The experience of women living with congenital adrenal hyperplasia: impact of the condition and the care given","volume":"85","author":"Engberg","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2025012117040311900_dgae710-B47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bmjsrh-2020-200868","article-title":"Cervical screening in women with classic congenital adrenal hyperplasia: uptake and barriers","volume":"47","author":"Devine","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"key":"2025012117040311900_dgae710-B48","author":"Ministry of Health and the United Nations Population Fund (UNFPA) in Vietnam"},{"issue":"3","key":"2025012117040311900_dgae710-B49","first-page":"10","article-title":"My Vietnam experience","volume":"3","author":"Konheiser","year":"2004","journal-title":"CARES Foundation Fall Newsletter"},{"issue":"3","key":"2025012117040311900_dgae710-B50","first-page":"12","article-title":"The state of children and teenagers with CAH in Vietnam","volume":"3","author":"Warne","year":"2004","journal-title":"CARES Foundation Fall Newsletter"},{"issue":"4","key":"2025012117040311900_dgae710-B51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/ijns6040076","article-title":"We all have a role to play: redressing inequities for children living with CAH and other chronic health conditions of childhood in resource-poor settings","volume":"6","author":"Armstrong","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"1","key":"2025012117040311900_dgae710-B52","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s13023-022-02527-y","article-title":"Rare disease education in Europe and beyond: time to act","volume":"17","author":"Tumiene","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"2025012117040311900_dgae710-B53","doi-asserted-by":"crossref","first-page":"103698","DOI":"10.1016\/j.ijnurstu.2020.103698","article-title":"Cochrane reviews of educational and self-management interventions to guide nursing practice: a review","volume":"110","author":"Coster","year":"2020","journal-title":"Int J Nurs Stud"},{"issue":"4","key":"2025012117040311900_dgae710-B54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S2213-8587(13)70138-4","article-title":"Management of adolescents with congenital adrenal hyperplasia","volume":"1","author":"Merke","year":"2013","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/Supplement_1\/S67\/61529824\/dgae710.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/Supplement_1\/S67\/61529824\/dgae710.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T17:04:27Z","timestamp":1737479067000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/Supplement_1\/S67\/7965811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":54,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2025,1,21]]},"published-print":{"date-parts":[[2025,1,21]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae710","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,1,21]]}}}